AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 2 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $519,283 | -2.9% | 7,430 | -0.2% | 0.01% | 0.0% |
| Q2 2023 | $534,998 | +15.3% | 7,445 | -1.0% | 0.01% | +20.0% |
| Q1 2023 | $463,834 | -39.4% | 7,520 | -24.3% | 0.01% | -44.4% |
| Q4 2022 | $765,901 | +59.2% | 9,930 | -7.9% | 0.01% | +50.0% |
| Q3 2022 | $481,000 | -17.2% | 10,780 | -29.0% | 0.01% | -14.3% |
| Q2 2022 | $581,000 | -6.4% | 15,180 | +1.1% | 0.01% | 0.0% |
| Q1 2022 | $621,000 | +14.6% | 15,010 | +4.7% | 0.01% | +16.7% |
| Q4 2021 | $542,000 | +0.7% | 14,335 | -12.2% | 0.01% | 0.0% |
| Q3 2021 | $538,000 | -14.6% | 16,325 | +74.9% | 0.01% | -14.3% |
| Q2 2021 | $630,000 | +24.0% | 9,335 | +4.0% | 0.01% | +16.7% |
| Q1 2021 | $508,000 | -13.5% | 8,980 | +24.6% | 0.01% | -33.3% |
| Q4 2020 | $587,000 | +17.6% | 7,205 | +2.9% | 0.01% | 0.0% |
| Q3 2020 | $499,000 | +55.9% | 7,000 | +79.7% | 0.01% | +50.0% |
| Q2 2020 | $320,000 | -12.8% | 3,895 | +9.7% | 0.01% | 0.0% |
| Q4 2019 | $367,000 | – | 3,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 785,683 | $60,599,730 | 58.10% |
| Fairmount Funds Management LLC | 2,011,647 | $155,158,333 | 24.61% |
| VR Adviser, LLC | 670,718 | $51,732,479 | 8.72% |
| Ghost Tree Capital, LLC | 235,000 | $18,126,000 | 7.74% |
| SVB FINANCIAL GROUP | 33,849 | $2,610,773 | 7.14% |
| Tri Locum Partners LP | 200,054 | $15,430,000 | 6.24% |
| BVF INC/IL | 1,755,000 | $135,363,150 | 5.71% |
| RTW INVESTMENTS, LP | 2,980,482 | $229,884,577 | 4.69% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $24,681,600 | 3.59% |
| PFM Health Sciences, LP | 1,092,831 | $84,290,055 | 3.02% |